About Dimethyl Fumarate DR

Dimethyl Fumarate DR Caps 120mg, 240mg and 120mg/240mg Starter Pak is AB-rated generic therapeutic equivalent version of Biogen IDEC Inc.’s Tecfidera®. It is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.


  • Store at 15°C to 30°C (59 to 86°F).
  • Protect the capsules from light.
  • Store in the original container.

Information for Patients

  • The most common side effects of dimethyl fumarate include:
    • flushing, redness, itching, or rash
    • nausea, vomiting, diarrhea, stomach pain, or indigestion
    • Flushing and stomach problems are the most common reactions, especially at the start of therapy, and may decrease over time. Taking dimethyl fumarate delayed-release capsules with food may help reduce flushing. Call your doctor if you have any of these symptoms and they bother you or do not go away. Ask your doctor if taking aspirin before taking dimethyl fumarate delayed-release capsules may reduce flushing.

Patients / Physicians / Pharmacists

For medical emergencies in USA, please call 911. Patients and other consumers should contact their physician with questions about prescription products and their common indications.

For any further medical information, to report an adverse event or product complaint, please call toll-free.